Results 121 to 130 of about 12,053 (162)

Residual risk in atherosclerotic cardiovascular disease after statin therapy: Clinical mechanisms and management strategies. [PDF]

World J Cardiol
Tan SH, Wu JL, Zhuo SX, Zhang Y, Wang M.
europepmc   +1 more source

Genetic Insights on Hypertriglyceridaemia-Induced Acute Pancreatitis in Pregnancy: A Case Series and Literature Review. [PDF]

Case Rep Endocrinol
Nguyen CS, Adams N, Gianatti E, Lee IL, Kevat D.   +4 more
europepmc   +1 more source

Data Mining of the FDA Adverse Event Reporting System and Animal Experiments for Assessment of Rhabdomyolysis Risk Associated with Lipid-lowering Drugs. [PDF]

Int J Med Sci
Kobuchi S, Sugiyama D, Iima A, Obuchi A, Osaka A, Doi A, Ueta H, Yokoyama S, Hosomi K, Takada M, Sakaeda T.   +10 more
europepmc   +1 more source

Multimodal Management of Extreme Hypertriglyceridemia in a Child with Recurrent Pancreatitis: Clinical Challenges and Solutions. [PDF]

J Clin Med
Spoială EL, Oltean C, Vasiliu I, Paduraru G, Danilă DC, Ghiga G, Țugui M, Butnariu LI, Cojocaru E, Trandafir LM.   +9 more
europepmc   +1 more source

Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis. [PDF]

Ann Gastroenterol
Dalekos GN, Gatselis N, Androutsakos T, Samonakis D, Triantos C, Tiniakos D, Rigopoulou EI, Hellenic Autoimmune Liver Diseases Study Group.   +7 more
europepmc   +1 more source

Evolving therapeutic landscape of primary biliary cholangitis: A review. [PDF]

World J Hepatol
Mitchell NE, Chan SY, Jerez Diaz D, Ansari N, Lee J, Twohig P.   +5 more
europepmc   +1 more source

Economic Burden of Primary Biliary Cholangitis by Line of Therapy in the United States. [PDF]

Adv Ther
Kumar S, Shamseddine N, Yang H, Zhang S, Ye D, Seshasayee S, Chen J, Kowdley KV.   +7 more
europepmc   +1 more source

Fibrations and cocategory

Commentarii Mathematici Helvetici, 1961
openaire   +2 more sources

Pathophysiology of Atherosclerotic Carotid Disease. [PDF]

Semin Neurol
Bo-Ran Ho B, Batarseh P, Dardik A.
europepmc   +1 more source

Epiafzelechin, a Flavanol, Regulates Lipid Homeostasis Through Modulation of HMGCR, PCSK9, and PPAR-α: Mechanistic Insights and Therapeutic Implications. [PDF]

Cardiovasc Ther
Alshammari SO, Shahzad N, Malik MNH, Alshammari QA, Alshammari A, Al Kazman BSM, Atif M, Solre GFB.   +7 more
europepmc   +1 more source